Ajanta Pharmaceuticals Ltd.
AJANTPHARMHealthcareR1 raw held document library
Coverage
| Dataset | On disk | Usable | State |
|---|---|---|---|
| Results XBRL (NSE + BSE) | 101 | 33 | 33 quarter-ends |
| Annual reports | 11 | 11 | identity graded |
| Earnings calls | 23 | 1 | transcripts and analyst meets only |
| Shareholding | 21 | 21 | |
| Related party | 6 | 6 | |
| Investor decks | 0 | 0 | cohort of 48 companies only |
Financial statements in parse — expected 19 Sep 2026. Nothing from the superseded legacy store is shown.
Earnings calls
23 transcript(s)/analyst meet(s) served; 22 document(s) on file are not transcripts (cover letters, duplicates, unresolved) and are excluded. Speaker attribution is shown only where the segmenter attributes ≥ 95% of sentences to management or analysts (0 of 23 documents here); elsewhere sentences render unattributed.
| Kind | Date | Period | Served | Attribution rate |
|---|---|---|---|---|
| COVER_LETTER | 20210504 | 2021-03-31 | no | |
| COVER_LETTER | 20210722 | 2021-06-30 | no | |
| COVER_LETTER | 20210802 | 2021-06-30 | no | |
| COVER_LETTER | 20211108 | 2021-09-30 | no | |
| COVER_LETTER | 20220204 | 2021-12-31 | no | |
| COVER_LETTER | 20220514 | 2022-03-31 | no | |
| TRANSCRIPT | 20220803 | 2022-06-30 | yes | |
| COVER_LETTER | 20221110 | 2022-09-30 | no | |
| COVER_LETTER | 20230213 | 2022-12-31 | no | |
| COVER_LETTER | 20230511 | 2023-03-31 | no | |
| COVER_LETTER | 20230802 | 2023-06-30 | no | |
| COVER_LETTER | 20231103 | 2023-09-30 | no | |
| COVER_LETTER | 20240205 | 2023-12-31 | no | |
| COVER_LETTER | 20240508 | 2024-03-31 | no | |
| COVER_LETTER | 20240802 | 2024-06-30 | no | |
| COVER_LETTER | 20241030 | 2024-09-30 | no | |
| COVER_LETTER | 20250203 | 2024-12-31 | no | |
| COVER_LETTER | 20250505 | 2025-03-31 | no | |
| COVER_LETTER | 20250731 | 2025-06-30 | no | |
| COVER_LETTER | 20251106 | 2025-09-30 | no | |
| COVER_LETTER | 20260205 | 2025-12-31 | no | |
| COVER_LETTER | 20260508 | 2026-03-31 | no | |
| COVER_LETTER | 20260803 | 2026-06-30 | no |